Dementia improvement with cytotoxic chemotherapy. A case of Alzheimer disease and multiple myeloma.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Archives of Neurology

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1997.00550160111024PMID 9109751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system.

  1996cited by this paper
• Role of the β‐amyloid protein in Alzheimer's disease

  1995cited by this paper
• Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

  1995cited by this paper
• Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

  1995cited by this paper
• Management of Gaucher disease. Current status and future directions: A roundtable discussion.

  1995cited by this paper
• Structural Determinants of the Alzheimer's Amyloid β‐Peptide

  1994cited by this paper
• Structural determinants of the Alzheimer's amyloid beta-peptide.

  1994cited by this paper
• Inflammatory mechanisms in Alzheimer's disease: implications for therapy.

  1994cited by this paper
• Clinical trial of indomethacin in Alzheimer's disease

  1993cited by this paper
• Molecular biology of the amyloid of Alzheimer's disease. An overview.

  1992cited by this paper
• Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

  1992cited by this paper
• Cytokines in Alzheimer's disease.

  1991cited by this paper
• False-positive results with PCR to detect leukaemia-specific transcript.

  1990cited by this paper
• Anti-inflammatory drugs and Alzheimer disease.

  1990cited by this paper
• The amyloid proteins of Alzheimer's disease as potential targets for drug therapy.

  1989cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• The Safety and Lack of Efficacy of Vinpocetine in Alzheimer's Disease

  1989cited by this paper
• A short test of mental status: description and preliminary results.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.

  1977cited by this paper
• Pharmacology of the nitrosoureas: an overview.

  1976cited by this paper
• Pharmacology of the nitrosoureas: an overview.

  1976cited by this paper
• Multiple myeloma: review of 869 cases.

  1975cited by this paper

• Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian colocalization study

  2024cites this paper
• The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer’s Disease

  2022cites this paper
• The potential use of O6-benzylg uanine, and O6-methylguanine for the treatment of alzheimer’s disease, and t. brucei group trypanosomes infections

  2022cites this paper
• Potential effect of natural and anabolizan steroids in elderly patient with COVID-19

  2020cites this paper
• Risk of Alzheimer’s Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries

  2020cites this paper
• Role of β2-microglobulin in postoperative cognitive decline.

  2017cites this paper
• Role of the Cell Cycle Re-Initiation in DNA Damage Response of Post-Mitotic Cells and Its Implication in the Pathogenesis of Neurodegenerative Diseases

  2016cites this paper
• Medical anticancer treatment of lung cancer associated with comorbidities: a review.

  2015cites this paper
• Effects of Hemodialysis on Profound Memory Deficits in Renal Insufficiency Due to Multiple Myeloma: A Case Study

  2009cites this paper
• Intrathecal corticosteroids might slow Alzheimer’s disease progression

  2008cites this paper
• BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease

  2007cites this paper
• Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease.

  2007cites this paper
• Oncogenic parallels in Alzheimer disease

  2006cites this paper
• Nonsteroidal Anti-Inflammatory Drugs and Alzheimer’s Disease

  1999cites this paper